Deeb George R, Soung George Y, Best Al M, Laskin Daniel M
Associate Professor, Department of Oral and Maxillofacial Surgery, Virginia Commonwealth University School of Dentistry, Richmond, VA.
Resident, Department of Oral and Maxillofacial Surgery, Virginia Commonwealth University School of Dentistry, Richmond, VA.
J Oral Maxillofac Surg. 2015 Oct;73(10):1926-31. doi: 10.1016/j.joms.2015.05.024. Epub 2015 Jun 6.
Although various prophylactic systemic antibiotic regimens have been suggested to minimize failure after dental implant placement, the role of antibiotics in implant dentistry is still controversial. The purpose of the present survey was to determine the current antibiotic prescribing habits of oral and maxillofacial surgeons in conjunction with routine dental implant placement to determine whether any consensus has been reached among such practitioners.
An electronic survey was sent by electronic mail to all members of the American College of Oral and Maxillofacial Surgeons. The questions asked were related to whether antibiotics were routinely prescribed either pre- or postoperatively during routine dental implant placement, and, if so, what antibiotics, dosage, frequency, and duration were used. The survey participants were also asked to specify whether they were in solo private practice, group private practice, academia, military, or "other." The results were tabulated and analyzed using SAS software. Descriptive statistics and χ(2) analyses were used.
A total of 217 members responded to the survey. Overall, 112 of 217 (51.6%) prescribed antibiotics preoperatively (95% confidence interval [CI] 50.0 to 58.2%) and 152 of 213 (71.4%) prescribed antibiotics postoperatively (95% CI 65.0 to 77.0%) during routine dental implant placement. Also, 72 (34%) indicated that they prescribed antibiotics both pre- and postoperatively. The most common preoperative regimen used was amoxicillin 2 g given 1 hour before the procedure (32%, n = 36). The most common postoperative regimen used was amoxicillin 500 mg 3 times daily for 5 days (53%, n = 81).
We found no consensus among oral and maxillofacial surgeons regarding the use of antibiotics in association with routine dental implant placement, the type of regimen to use, or whether such use is even effective in preventing early implant loss. Furthermore, most of the antibiotic regimens being used are not in accordance with the recommendations current in the published data.
尽管已提出各种预防性全身抗生素治疗方案以尽量减少牙种植体植入后的失败情况,但抗生素在种植牙科中的作用仍存在争议。本次调查的目的是确定口腔颌面外科医生在常规牙种植体植入时目前的抗生素处方习惯,以确定这些从业者之间是否已达成任何共识。
通过电子邮件向美国口腔颌面外科医师协会的所有成员发送了一份电子调查问卷。所提问题涉及在常规牙种植体植入期间是否在术前或术后常规开具抗生素,如果是,使用了哪些抗生素、剂量、频率和疗程。还要求参与调查者指明他们是个体私人执业、团体私人执业、学术界、军队还是“其他”。使用SAS软件对结果进行列表和分析。采用描述性统计和χ²分析。
共有217名成员回复了调查。总体而言,在常规牙种植体植入期间,217名中有112名(51.6%)在术前开具抗生素(95%置信区间[CI]50.0至58.2%),213名中有152名(71.4%)在术后开具抗生素(95%CI65.0至77.0%)。此外,72名(34%)表示他们在术前和术后都开具抗生素。术前最常用的治疗方案是在手术前1小时给予阿莫西林2克(32%,n = 36)。术后最常用的治疗方案是阿莫西林500毫克,每日3次,共5天(53%,n = 81)。
我们发现口腔颌面外科医生在与常规牙种植体植入相关的抗生素使用、使用的治疗方案类型或这种使用是否甚至能有效预防早期种植体丢失方面未达成共识。此外,目前使用的大多数抗生素治疗方案不符合已发表数据中的现行建议。